Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. T.S. (Tjip) van der Werf

Publicaties

Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: An individual participant data meta-analysis

Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study

Isoniazid and rifampicin exposure during treatment in drug-susceptible TB

Non-restrictive open vial policy combined with the home visit vaccinations for improving BCG coverage in a high-incidence outreach region: A model-based cost-effectiveness analysis for Indonesia

Personalized Tuberculosis Care for Drug-Resistant Tuberculosis

Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial

Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model

Clinical relevance of rifampicin-moxifloxacin interaction in isoniazid resistant/intolerant tuberculosis patients

Clinical standards for drug-susceptible TB: putting patients first

Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis

Lees meer